Wegovy is a registered trademark of Novo Nordisk A/S. It is an FDA-approved prescription medicine. A licensed clinician must evaluate each patient and decide whether prescribing it is appropriate.
Important safety information: Wegovy has a boxed warning about the risk of thyroid C-cell tumors. It should not be used by anyone with a personal or family history of medullary thyroid carcinoma or with Multiple Endocrine Neoplasia syndrome type 2. Other important serious risks include pancreatitis, gallbladder problems, low blood sugar when used with certain diabetes medicines, acute kidney injury related to dehydration, serious allergic reactions, severe stomach problems, increased heart rate, and suicidal behavior or thinking. Read the complete official Wegovy Prescribing Information and Medication Guide, including the boxed warning, indications, contraindications, warnings, and adverse reactions. A clinician should weigh the potential benefits and risks for each person.
This page is general information, not medical advice. Talk to a licensed clinician about your situation.
Nobody can answer this question from the outside. Whether your benefit covers this prescription is written into your specific plan document, and the only honest path is to go read it or ask the people who administer it.
The plan sponsor decides, not the insurer
A single insurance company administers many separate benefit designs. The employer or plan sponsor picks which drug categories are included, which are excluded, and what clinical criteria apply.
That is why two people carrying cards from the same insurer can get opposite answers. It is also why a coworker's experience, a forum post, or a number from a search result tells you almost nothing about your own benefit.
The sources that count are your current formulary document, your summary of benefits and coverage, your member portal, and your plan administrator.
The five questions to ask your plan
Call member services or sign in to the portal and ask, in this order:
- Is this prescription on my current formulary, and on which tier?
- Is there a benefit exclusion for weight-management prescriptions on my plan?
- Does it require prior authorization, step therapy, or a quantity limit?
- Which documented indications does the plan review, and what records are expected?
- Which pharmacies are in network, and is mail order required?
Ask for the answers in writing through the portal message center if you can. Write down the date. Formularies are often revised at the start of a plan year.
The documented use drives the decision
Plans review the indication, which is the documented clinical reason a prescription is written. Wegovy carries more than one FDA-approved indication in its labeling, and a plan can treat those uses differently.
A plan may review one documented use under one set of criteria and apply stricter criteria, or an outright exclusion, to another. This is the single most common place where a request goes wrong.
Ask your plan which indications it reviews and exactly what documentation it expects for each. Ask your clinician which indication fits your medical record. If those two answers do not line up, resolve that before anything is submitted.
What happens when prior authorization is required
Prior authorization is a paperwork review against written criteria. Your clinician submits records, the plan compares them to its rules, and it approves or denies.
Approvals are often time-limited. Ask how long an approval lasts and what a renewal requires, because a lapsed authorization can interrupt a fill without warning.
If a request is denied, the plan must give you the reason and the appeal process. Appeals are ordinary. Many denials come down to a record the plan asked for and never received, and supplying it resolves the matter.
Plan types behave differently
Employer and individual commercial plans set their own drug benefits, and this is where the widest variation lives. A manufacturer savings offer may apply here if you qualify.
Medicare Part D plans operate under federal program rules and their own formularies, and manufacturer commercial savings offers generally exclude government program beneficiaries. Medicaid coverage varies by state.
Whatever the plan type, ask about the benefit in front of you rather than assuming a category-wide rule applies to your case.
Savings programs are not coverage
Novo Nordisk runs savings and self-pay programs, and the official Wegovy cost and coverage page carries the current terms.
A savings program lowers what you pay. It does not make a plan cover something the plan excludes, and it usually carries conditions on insurance type, product, fill period, maximum savings, and expiration. Read the live terms before you rely on any advertised figure.
How Body Good can help, and what it cannot do
Body Good provides coverage support. That means a benefits check, help assembling the documents your plan requests, prior authorization submission support, and pharmacy routing.
Approval and payment are determined by the plan, not by Body Good. Support does not guarantee coverage, an approval, or any particular out-of-pocket amount, and no service can promise what a plan will decide.
Body Good's prices are service fees for the program described during intake. They are not the price of medication and are not a quote for any individual. Eligibility is determined by a clinician.
Coverage support for the Wegovy pen carries a Body Good service fee of $75 per month, $195 for three months, or $95 one time. The one-time option covers a single initial consultation and one prior authorization submission attempt, with no further coverage support after that initial decision, and refunds are not provided if coverage is denied. Medication cost is separate and not included.
This website is an informational and pricing overview. It does not accept payment, collect protected health information, or operate an intake form. Intake and checkout happen on joinbodygood.com.
Plan for both answers before you ask
Decide in advance what you will do if the answer is yes and what you will do if it is no. If the benefit exists, your next steps are the tier, the criteria, and the deductible. If it does not, your next steps are the self-pay terms and a conversation with your clinician about the full range of appropriate options.
Either way, the decision about what to prescribe belongs to a licensed clinician who has evaluated you. Coverage shapes what a course of care costs. It does not decide what is medically appropriate.
Frequently asked questions
Will my insurance cover Wegovy?
Only your plan can answer that. Check your current formulary, look for a weight-management benefit exclusion, and ask member services about tier, prior authorization, and the indications the plan reviews.
What should I do if my request is denied?
Ask for the written reason and the appeal instructions. Many denials are documentation problems rather than medical ones, and an appeal supported by the specific records the plan named is a normal next step.
Does Body Good's fee include the medication?
No. Body Good charges a service fee for the program described during intake. Any prescribed medication is billed separately by a pharmacy or another authorized provider. Begin the secure intake for clinical review.
Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. Body Good is not affiliated with, endorsed by, sponsored by, or authorized by Eli Lilly and Company or Novo Nordisk A/S. All trademarks are the property of their respective owners.